期刊文献+

A study of recombinant protective H.Pylori antigens 被引量:20

A study of recombinant protective H.Pylori antigens
下载PDF
导出
摘要 AIM: To construct a recombinant vector which can express Mr 26 000 outer membrane protein (OMP) from Helicobacter pylori (Hp), and to obtain the vaccine protecting against Hp infection and a diagnostic reagent kit quickly detecting Hp infection.METHODS: The gene encoding the structural Mr 26000 outermembrane protein of Hp was amplified from Hpchromosomal DNA by PCR, and inserted in the prokaryoticexpression vector pET32a ( + ), which was transformed intothe Topl0 E. coli strain. Recombinant vector was selected,identified and transformed into BL-21(DE3) E. coli strain.The recombinant fusion proteins were expressed. Theantigenicity of recombinant protein was studied by ELISA orimmunoblotting and immunized Balb/c mice.RESULTS: The gene of Mr 26 000 OMP was amplified to be594 base pairs, 1.1% of the cloned genes was mutated and1.51% of amino acid residues was changed, but there washomogeneity between them. The recombinant fusion proteinencoded objective polypeptides of 198 amino acid residues,corresponding to calculated molecular masses of Mr 26000.The level of soluble expression products was about 38.96 %of the total cell protein. After purification by Ni-NTA agaroseresin columniation, the purity of objective protein becameabout 90 %. The EESA results showed that recombinantfusion protein could be recognized by patient serum infectedwith Hp and rabbit serum immunized with the recombinantprotein. Furthermore, Balb/ c mice immunized with therecombinant proteln were protected against H. pyloriinfection.CONCLUSION: Mr 26 000 OMP may be a candidate vaccinepreventing Hp infection. AIM:To construct a recombinant vector which can express M,26000 outer membrane protein(OMP)from Helicobacter pylori(Hp),and to obtain the vaccine protecting against Hp infection and a diagnostic reagent kit quickly detecting Hp infection. METHODS:The gene encoding the structural M_r 26000 outer membrane protein of Hp was amplified from Hp chromosomal DNA by PCR,and inserted in the prokaryotic expression vector pET32a(+),which was transformed into the Top10 E.coli strain.Recombinant vector was selected, identified and transformed into BL-21(DE3)E.coli strain. The recombinant fusion proteins were expressed.The antigenicity of recombinant protein was studied by ELISA or immunoblotting and immunized Balb/c mice. RESULTS:The gene of M_r 26 000 OMP was amplified to be 594 base pairs,1.1% of the cloned genes was mutated and 1.51% of amino acid residues was changed,but there was homogeneity between them.The recombinant fusion protein encoded objective polypeptides of 198 amino acid residues, corresponding to calculated molecular masses of M_r 26000. The level of soluble expression products was about 38.96 % of the total cell protein.After purification by Ni-NTA agarose resin columniation,the purity of objective protein became about 90 %.The ELISA results showed that recombinant fusion protein could be recognized by patient serum infected with Hp and rabbit serum immunized with the recombinant protein.Furthermore,Balb/ c mice immunized with the recombinant protein were protected against H.pylori infection.CONCLUSION: Mr 26 000 OMP may be a candidate vaccine preventing Hp infection.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2002年第2期308-311,共4页 世界胃肠病学杂志(英文版)
  • 相关文献

参考文献2

二级参考文献33

  • 1[1]Parsonnet J,Friedman GD,Vandersteen DP.Helicobacter pylori infection and the risk of gastric carcinoma.New Engl J Med,1991; 325:1127 - 1131 被引量:1
  • 2[2]Parsonnet J,Hansen S,Rodriguez L.Helicobacter pylori infection and gastric lymphorma.NewEnglJMed,1994;330:1267-1271 被引量:1
  • 3[3]Wotherspoon AC.Gastric MALT lymphoma and Helicobacter pylori.Yale J Biol Med,1997;69:61-68 被引量:1
  • 4[4]The European Helicobacter pylori study Group (EHPSA).Current european concepts in the management of Helicobacter pylori infection-the Maastricht consensus report.Gut,1997;41:8 - 13 被引量:1
  • 5[7]Hansson LE,Nyren O,Hsing AW.The risk of stomach cancer in patients with gastric cancer or duodenal ulcer disease.New Engl J Med,1996; 335:242 - 249 被引量:1
  • 6[8]Cerutti PA.Oxy-radicals and cancer.Lancet,1994;344:862-863 被引量:1
  • 7[9]Renault B,Van den Broek M,Fodde R.Base transitions are the most frequent genetic changes at p53 in gastric cancer.Cancer Res,1993; 53:2614 - 2617 被引量:1
  • 8[10]Hongyo T,Buzard GS,Palli D.Mutations of the K-ras and p53 genes in gastric edenocarcinoma from a hign-incidence ragion around Florence,Italy.Cancer Res,1995; 55:2665 - 2672 被引量:1
  • 9[11]Imazeki F,Omata M,Nose H,Ohto M,Isono K.p53 gene mutations in gastric and esophagel Cancers.Gastroenterology,1992; 103:892 - 896 被引量:1
  • 10[13]Nakatsura S,Yanagisawa A,Ichii S.Somatic mutations of the APC gene in gastric cancer:freguent mutations in very well differentiated adenocarcinoma and signet ring cell carcinoma.Hum Mol Genet,1992; 1:559 - 563 被引量:1

共引文献99

同被引文献101

引证文献20

二级引证文献74

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部